• Diagnosis​ ​Info​ ​and​ ​General​ ​Questions

  Viltolarsen Earns European Orphan Drug Status as Duchenne Treatment

  Posted by md-forums-moderator on June 15, 2020 at 9:02 am

  The European Commission has granted orphan drug designation to viltolarsen, a therapy for Duchenne muscular dystrophy patients amenable to exon 53 skipping. Click here to read more.

  What do you think of this news?

  md-forums-moderator replied 3 years, 10 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply